glp-1 out of pocket RA prior authorization and out-of-pocket costs rise from 2020 to 2025 Costly GLP-1 Drugs are Rarely

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

Excited to share my recent certification in () through GxP training

These medications also delay gastric emptying through neural mechanisms, increasing the risk for perioperative aspiration during anaesthesia and sedation

In recent years, glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become central in the treatment of type 2 diabetes (T2D)

Eli Lillys decision to hike the UK list price of its weight-loss drug Mounjaro by as much as 170% isnt just about affordability

Explore Lambda's full-service clinical development solutions for semaglutide, supporting GLP-1 RA programs aligned with FDA & EMA requirements.